The University of Maryland School of Pharmacy offers an ASHP-accredited two-year PGY1/PGY2 Residency in Pharmacotherapy.
PGY1 Pharmacotherapy: PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
PGY2 Pharmacotherapy: The PGY2 pharmacy residency in pharmacotherapy is designed to produce a specialized with an advanced degree of proficiency and expertise in working with interdisciplinary teams to deliver pharmaceutical care to diverse populations from ambulatory to critically ill, pediatrics to older adults and presenting with varied and complex health problems. The intense focus on direct patient care of this residency develops a specialist of great flexibility in the direct patient care arena, an individual who can move from one specialized area of practice to another with confidence and ease. While other clinical specialized residencies build a knowledge base and decision-making skills in one area of focus, the pharmacotherapy residency graduate refines the decision-making skill in such a way that it is transferable across practice areas and then supplements that skill with strong knowledge acquisition in a broad range of disease states. Upon completion of the pharmacotherapy residency, residents will be well-equipped to obtain a position in academia or as a clinical pharmacy specialist.
This video provides a detailed overview of the PGY1/PGY2 Pharmacotherapy Residency Program available through a partnership between the University of Maryland School of Pharmacy and the University of Maryland Medical Center, and includes information about what residents can expect to learn during their time in the program.
Our program adheres to the required Goals and Objectives for a Postgraduate Year One (PGY1) Pharmacy Residencies and the required Goals and Objectives for Postgraduate Year Two (PGY2) Pharmacotherapy Residencies set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.
Objectives:
- Develop individuals with a strong foundation of skills and knowledge to practice as a clinical pharmacist caring for a wide variety of patients in an institutional environment.
- Allow individuals to practice as an independent practitioners working with other healthcare providers to provide optimal medication therapy in a wide variety of institutional patient care areas.
- Demonstrate proficiency in teaching and scholarly activity and the development of these skills.
- Prepare the resident to attain board certification as a pharmacotherapy specialist.
Clinical Experiences:
Clinical rotations, which include inpatient and outpatient experiences, take place at the University of Maryland Medical Center (UMMC), University of Maryland Medical Center Midtown Campus, and the Baltimore Veterans Affairs Hospital.
Required Rotations: Adult Internal Medicine, Medical Intensive Care Unit, Cardiology, Infectious Diseases, Psychiatry, Management, Pediatrics, Oncology, Transplantation, Emergency Department, Research, Teaching Certificate Program and Longitudinal Ambulatory Care Rotations over 24 months.
Elective Rotations (Up to 4):
- ICU (Cardiac Surgery ICU, Surgical ICU, Neuro Critical Care ICU, Trauma ICU, etc.)
- Infectious disease (Global, HIV, Medicine, Oncology, Transplant etc.)
- Pain and Palliative Care
- Teaching
- Toxicology
PGY1 Example Rotation Schedule
| Rotation/Committee | July | August | September | October | November | December |
|---|---|---|---|---|---|---|
| Rotation | Orientation | IM | IM | IM | MICU | MICU |
| Rotation | -- | Ambulatory Longitudinal Anticoagulation Clinic | -- | |||
| Committee | -- | VTE | VTE | VTE | VTE | -- |
| Rotation/Committee | January | February | March | April | May | June |
|---|---|---|---|---|---|---|
| Rotation | Cards - PCS | Cards - AHFS | Micro-ID Consults | Med-ID | Psych | Management |
| Rotation | Ambulatory Longitudinal CHF | Ambulatory Longitudinal HIV | ||||
| Committee | PMEADE | PMEADE | PMEADE | MEADE | MEADE | MEADE |
PGY2 Example Rotation Schedule
| Rotation/Committee | July | August | September | October | November | December |
|---|---|---|---|---|---|---|
| Rotation | Neuro ICU | IM | MICU | Peds/PICU | CSICU | Research |
| Rotation | Ambulatory Longitudinal Neurology | Ambulatory Longitudinal Family Medicine | ||||
| Committee | P&T | P&T | P&T | Insulin | Insulin | Insulin |
| Rotation/Committee | January | February | March | April | May | June |
|---|---|---|---|---|---|---|
| Rotation | Teaching | IM (Precepting) | Transplant | Oncology | EM | IM |
| Rotation | Ambulatory Longitudinal Hep C | Ambulatory Longitudinal Transplant Clinic | ||||
| Committee | ASC | ASC | ASC | Med Rec | Med Rec | Med Rec |
In addition to these unique experiences, the pharmacotherapy resident is expected to participate in Pharmacotherapy Rounds, the Professional Development Seminar Series, School of Pharmacy teaching activities, Case Conferences and Literature Updates For more information about these specific activities, please click here.
Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and eligibility for Maryland Pharmacist licensure are required.
Application Process:
Number of available positions: 1
Applications for this program will only be accepted through PhORCAS.
Three letters of recommendation using the standard reference template in PhORCAS are required.
The application deadline is January 2.
International students and permanent residents should contact P-SHORResidencyandAdministrativeSupport@rx.umaryland.edu before applying.
Residency Advisory Committee:
- Matthew Bathula, PharmD, BCPS
- Emily Heil, PharmD, MS, BCIDP, BCPS, AAHIVP
- Ashley Martinelli, PharmD, BCEMP, BCCCP
- Richard Rovelli, PharmD, BCCP
Past Residents:
Alyssa Castillo, PharmD (2022-2024)
Clinical Assistant Professor and Internal Medicine Pharmacist
Texas A&M University Irma Lerma Rangel School of Pharmacy
Marisa Rinehart, PharmD, BCPS (2020-2022)
Acute Care Pharmacist, Neurosciences
Atrium Health Wake Forest Baptist Medical Center
Christopher Medlin, PharmD, BCPS (2018-2020)
Clinical Assistant Professor and Internal Medicine Pharmacist
The University of Texas at El Paso School of Pharmacy
Anne Masich, PharmD, BCPS (2016-2018)
Assistant Professor and Internal Medicine Pharmacist
Virginia Commonwealth University School of Pharmacy
Ryan D’Angelo, PharmD, BCPS (2014-2016)
Clinical Pharmacy Specialist, Cardiology
The Hospital of the University of Pennsylvania
Rachel Flurie, PharmD, BCPS (2012-2014)
Associate Professor and Internal Medicine/Nephrology Pharmacist
Virginia Commonwealth University School of Pharmacy
Program Director:
Asha L. Tata, PharmD, BCPS
Internal Medicine Clinical Pharmacist
Clinical Associate Professor, University of Maryland School of Pharmacy
University of Maryland Medical Center Department of Pharmacy Services
29 South Greene Street, Suite 400
Baltimore, MD 21201
Phone: 410-328-6108
Fax: 410-328-6781
Email: atata@umm.edu
Program Coordinator:
Mojdeh S. Heavner, PharmD, BCPS, BCCCP, FCCM
Associate Professor and Vice Chair for Clinical Services
University of Maryland School of Pharmacy
20 North Pine Street, Room N427
Baltimore, MD 21201
Phone: 410-706-3498
Fax: 410-706-6580
Email: mheavner@rx.umaryland.edu